Full Episode
Friday, Oct 3
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

A free press is a cornerstone of a healthy democracy

Support trusted journalism and civil dialogue
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

oxycontin

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Oct 21

Drug companies reach tentative deal to settle opioids lawsuit

By Julie Carr Smyth, Geoff Mulvihill, Associated Press

The tentative deal settles claims by state and local governments against distributors AmerisourceBergen, Cardinal Health and McKessen and the manufacturer Teva.

Continue reading

Sep 16

Why bankruptcy might not get opioid-maker Purdue Pharma off the hook

By Geoff Mulvihill, Associated Press

Some states have made it clear they intend to continue their lawsuits against members of the Sackler family in state courts.

Continue reading

Sep 16

Purdue Pharma files for bankruptcy as part of opioids settlement

By Geoff Mulvihill, Associated Press

The bankruptcy filing was anticipated before and after a tentative settlement deal, which could be worth up to $12 billion over time, was struck.

Continue reading

Sep 12

Some states say they’ll keep fighting Purdue Pharma in court

By Geoff Mulvihill, Dave Collins, Associated Press

Courtroom showdowns still face OxyContin maker Purdue Pharma and the family that owns it, the Sacklers. But after a tentative settlement reached Wednesday with thousands of local governments and more than 20 states, the fight will be less about the…

Continue reading

Sep 11

OxyContin maker agrees to tentative settlement, attorneys say

By Geoff Mulvihill, Dave Collins, Associated Press

Attorneys representing some 2,000 local governments say they have agreed to a tentative settlement with OxyContin maker Purdue Pharma over the toll of the nation's opioid crisis.

Continue reading

Aug 28

OxyContin maker negotiating settlement worth a reported $12B

By Andrew Welsh-Huggins, Associated Press

Purdue Pharma, the maker of the prescription painkiller OxyContin, is facing billions of dollars in potential liability for its role in the nation's opioid crisis.

Continue reading

May 16

5 states announce new lawsuits over prescription opioids

By Anthony Izaguirre, Geoff Mulvihill, Associated Press

With the suits, 45 states are now taking legal action against OxyContin maker Purdue Pharma, asserting that the company downplayed the addiction risks of its powerful prescription drug.

Continue reading

Mar 31

Watch 9:33
Sackler family faces continuing legal issues over OxyContin

The Sackler family, once known for philanthropy, has been embroiled in lawsuits and settlements to keep details of its pharmaceutical company's activities out of public view. Purdue Pharma is the maker of the highly addictive opioid OxyContin. Author and former…

Continue watching

Mar 26

Oklahoma settles with maker of OxyContin over opioid crisis

By Ken Miller, Geoff Mulvihill, Associated Press

The maker of the powerful prescription painkiller OxyContin has reached a settlement with the state of Oklahoma over its role in the nation's deadly opioid crisis, officials said Tuesday. The terms were not immediately disclosed.

Continue reading

Feb 01

Purdue Pharma family sought to profit off opioid crisis, filing alleges

By Alanna Durkin, Geoff Mulvihill, Associated Press

While aggressively marketing OxyContin, the Sackler family also sought to profit off the drug abuse crisis its company helped create by exploring selling drugs used to treat addiction and reverse overdoses, state lawyers contend in previously secret parts of their…

Continue reading

Jump to the First Page Previous Page
1 2 3 4
Next Page Jump to the Last Page

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Oct 3
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You